Etiology of Uncomplicated Fever in Children <5 in Rural Zanzibar (RDTNEG)

December 2, 2014 updated by: Anders Björkman, Karolinska University Hospital

Infectious Disease Etiologies of Uncomplicated Febrile Illness in Children <5 Years of Age in Rural Zanzibar

The purpose of this study is to study the most common etiologies of uncomplicated fever diseases among children under five years of age in rural Zanzibar.

Study Overview

Status

Completed

Detailed Description

During the last 6 years Zanzibar has undergone a dramatic change in malaria epidemiology and burden of disease, with a marked decline of Plasmodium falciparum malaria among febrile children from approximately 30% to 1% or below and a reduction of crude child mortality of 50%. Millions of children in Africa die of neonatal disorders, acute respiratory tract infections (ARI), diarrhea, malaria, measles, HIV and malnutrition. A majority of these illnesses are also a common cause of febrile illness in out-patient departments. However, most of the few fever studies made in Africa are hospital based Very few studies on etiology of childhood febrile disease have been conducted on first level health facilities in the least developed countries in Africa. This study will therefore focus on children between 2 months to 5 years of age that have been diagnosed with a negative rapid diagnostic test (RDT) for malaria and their causes of fever at the first referral level in out-patient clinics in Zanzibar.

Study Type

Observational

Enrollment (Actual)

690

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zanzibar
      • Kivunge, Zanzibar, Tanzania
        • Facility: Primary health care center (PHCC), Kivunge, North A district, Zanzibar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Kivunge Primary Health Care Center (PHCC) in North A District in Zanzibar

Description

Inclusion Criteria:

  • Patients between 2-59 months of age with confirmed fever, with a measured axillary temperature of ≥37.5˚C, or history of fever within the preceding 24 hours.
  • Presenting at the health facility from 8.00 to 16.00 Monday to Friday.
  • Informed consent.
  • Able and willing to complete stipulated follow-up.

Exclusion Criteria:

  • Decision by the clinician to refer the patient to another health facility than the PHCC where the study is conducted.
  • Symptoms/ signs of severe disease that requires immediate referral from the PHCC as defined by the clinicians. These symptoms/signs of severe disease are according to the IMCI guidelines.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
relative frequency of febrile diseases etiology
Time Frame: Five months
Five months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anders Björkman, Professor, Karolinska University Hopsital
  • Principal Investigator: Magnus Lindh, Professor, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Principal Investigator: Mwinyi Msellem, MSc, Zanzibar Malaria Control Programme
  • Principal Investigator: Abdullah S. Ali, Manager, Zanzibar Malaria Control Programme
  • Principal Investigator: Birger Trollfors, Professor, Sahlgrenska University Hospital, Gothenburg, Sweden
  • Principal Investigator: Andreas Mårtensson, MD, PhD,, Karolinska University Hospital
  • Principal Investigator: Kristina Elfving, M.D., Sahlgrenska University Hospital, Gothenburg, Sweden
  • Principal Investigator: Delér Shakely, M.D., Karolinska University Hopsital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

March 26, 2010

First Submitted That Met QC Criteria

March 26, 2010

First Posted (Estimate)

March 29, 2010

Study Record Updates

Last Update Posted (Estimate)

December 3, 2014

Last Update Submitted That Met QC Criteria

December 2, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infectious Disease

3
Subscribe